- June 15, 2023
- progress
bugTDX
Platforms
About
bugTDX is a single player casual simulation game. It was developed by progress and was released on June 15, 2023. It received overwhelmingly positive reviews from players.
"BugTDX is a tower defense game with a wide variety of towers to purchase and level up, offering numerous synergies and strategies. Enemies come in different types, including flying ones, requiring careful planning and tower choices. The game features high replayability with increasing difficulty levels, random modifiers, and secret towers, encouraging experimentation and adaptation for success."





- Fun and addictive gameplay that cleverly combines tower defense and auto battler mechanics.
- Variety of towers and interesting synergies provide a unique experience.
- Active developer with potential for future updates and improvements.
- Game feels incomplete with many quality of life issues and balance problems, especially at higher difficulties.
- Graphics and UI need significant improvements to enhance the overall experience.
- Gameplay mechanics can lead to frustrating situations where players feel stuck due to tower availability and shop randomness.
- graphics6 mentions Positive Neutral Negative
The graphics of the game receive mixed feedback; while some players appreciate the visuals and music, many feel that significant improvements and enhancements are needed. Overall, the gameplay is praised, suggesting that the graphics may not detract significantly from the overall experience for some players.
“I really like the graphics and music.”
“Fun tower defense game, if you don't mind the graphics.”
Games Like bugTDX
Frequently Asked Questions
bugTDX is a casual simulation game.
bugTDX is available on PC and Windows.
bugTDX was released on June 15, 2023.
bugTDX was developed by progress.
bugTDX has received overwhelmingly positive reviews from players. Most players liked this game for its graphics but disliked it for its story.
bugTDX is a single player game.
Similar games include 9 Kings, Tower Tactics: Liberation, Genome Guardian, FLERP, SNKRX and others.





